Group One Trading
HRMY icon

Group One Trading’s Harmony Biosciences HRMY Stock Holding History

Group One Trading’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-242
Closed -$9.68K – 7556
2024
Q3 		$9.68K Buy
+242
New +$8.5K ﹤0.01% 5617
2023
Q2 		– Sell
-4,117
Closed -$142K – 7893
2023
Q1 		$134K Buy
+4,117
New +$187K ﹤0.01% 4033

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Group One Trading's HRMY Position: Q4 2024 in Review

Group One Trading sold out of Harmony Biosciences (HRMY) in Q4 2024, closing a stake of 242 shares — an estimated $9.68K sold.

Group One Trading first reported a position in HRMY in Q1 2023 and held it in 2 quarters. The position peaked at $134K in Q1 2023. 247 funds tracked by Wall St. Rank hold HRMY as of Q4 2024.

  • Group One Trading reported no remaining Harmony Biosciences position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 242 Harmony Biosciences shares in Q4 2024, an estimated $9.68K.
  • Group One Trading first reported a position in Harmony Biosciences in Q1 2023 and held it in 2 quarters.
  • Group One Trading's Harmony Biosciences position peaked at $134K in Q1 2023.
  • 247 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.